The Debarment Enforcement of Bad Actor Registrants Act of 2021 (“DEBAR Act”) authorizing the Drug Enforcement Administration (DEA) to bar an entity from registering to manufacture, distribute, or dispense controlled substances for recurrent suspensions or registrations is awaiting the President’s signature.
Passed by Congress last week, DEBAR will allow the DEA temporarily or permanently—the registration of an entity that (1) meets or has met any condition for suspension or revocation of the registration, and (2) has a history of prior suspensions or revocations.
About Solutions Law Press, Inc.™
Solutions Law Press, Inc.™ provides human resources and employee benefit and other business risk management, legal compliance, management effectiveness and other coaching, tools and other resources, training and education on leadership, governance, human resources, employee benefits, data security and privacy, insurance, health care and other key compliance, risk management, internal controls and operational concerns. If you find this of interest, you also be interested reviewing some of our other Solutions Law Press, Inc.™ resources available at http://www.solutionslawprrss.com
slphealthcareupdate.com 